CN101143815B - Method for preparing felbinac - Google Patents

Method for preparing felbinac Download PDF

Info

Publication number
CN101143815B
CN101143815B CN200710052668A CN200710052668A CN101143815B CN 101143815 B CN101143815 B CN 101143815B CN 200710052668 A CN200710052668 A CN 200710052668A CN 200710052668 A CN200710052668 A CN 200710052668A CN 101143815 B CN101143815 B CN 101143815B
Authority
CN
China
Prior art keywords
felbinac
biphenyl
chloromethylation
biphenylacetic
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200710052668A
Other languages
Chinese (zh)
Other versions
CN101143815A (en
Inventor
祝宏
刘永琼
潘盛钢
高霞
李胜松
邹莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Institute of Technology
Original Assignee
Wuhan Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Institute of Technology filed Critical Wuhan Institute of Technology
Priority to CN200710052668A priority Critical patent/CN101143815B/en
Publication of CN101143815A publication Critical patent/CN101143815A/en
Application granted granted Critical
Publication of CN101143815B publication Critical patent/CN101143815B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a preparation method of the biphenylacetic aicd of a non-steroidal anti-inflammatory drug, which includes two steps. The first step is to synthesize the biphenylacetic aicd, biphenyl is used as material, and a crude biphenylacetic aicd product is synthesized by chloromethylation, grignard reaction and hydrolysis, wherein, the molar ratio of the biphenyl, formaldehyde, phosphoric acid and acetic acid is 1:1:3:3, concentrated hydrochloric acid is overdosed, while the chloromethylation reacts, chlorine hydride gas is infused into reaction solution, and the flow of the chlorine hydride gas is 1 to 50l/h; the second step is refinement, the crude biphenylacetic aicd product produced in the first step is recrystallized by utilizing thirty to seventy percent (weight) of acetic acid solution, so that a pure biphenylacetic aicd product is produced. In the reaction process, the invention does not use and generate compounds with high toxicity and has little environmental pollution; materials can be easily got, and prices are low; all the used devices are conventional mechanical devices, operation is simple, and the total yield of crude products is thirty eight to fortysix persent.

Description

The preparation method of felbinac
Technical field
The present invention relates to the preparation method of chemosynthesis field of medicaments, particularly a kind of non-steroid anti-inflammatory agent felbinac.
Background technology
Felbinac is a kind of NSAID (non-steroidal anti-inflammatory drug), the similar fenbufen of anti-inflammatory activity, have anti-inflammatory analgesic and good transdermal performance, its 3% gel ointment is widely used in arthritis deformans, scapulohumeral periarthritis, tenosynovitis, myalgia, soft tissue injury etc., has higher effective and security.In September, 1986 Japan Lederle company with " Napageln " be the ointment of trade(brand)name first in Japan's listing, afterwards this medicine again with trade(brand)name " Traxamgel " in Britain's listing, this medicine goes on the market in tens countries at present.According to the domestic and foreign literature report, kind surplus the synthetic route of felbinac has ten, starting raw material just has seven kinds.For example:
(1) with to bromo-acid or to the bromo-acid ethyl ester be raw material can one step or synthetic felbinac of two steps, being that the raw material synthetic route is as follows to bromo-acid:
Figure G2007100526680D00011
Though operational path is short, simple to operate, expensive raw material price, be difficult for obtaining the cost height;
(2) be raw material with 4-xenyl formaldehyde, wherein a synthetic route is as follows:
Figure G2007100526680D00012
This route complicated operation, productive rate are low, and raw material is difficult for obtaining the cost height;
(3) be raw material with benzyl cyanide and biphenyl acetonitrile, big for environment pollution, also big to the murder by poisoning of operator's health, be to be the synthetic route of raw material with the benzyl cyanide below:
Figure G2007100526680D00013
(4) with the toluylic acid be raw material, complicated operation, productive rate are low, and synthetic route is as follows:
Figure G2007100526680D00014
(5) cheap and easy to get because of biphenyl, normally be the synthetic felbinac of raw material with biphenyl, synthetic route just has five kinds at present, but mostly complicated operation, pollute that agents useful for same is difficult to preparation in big, the reaction process, wherein a synthetic route is as follows:
In sum, each operational path all is not suitable for carrying out enterprise's production more than.
Summary of the invention
Technical problem to be solved by this invention be the deficiency that exists at prior art and provide a kind of simple to operate, pollutions is little, cost is low, be easy to a kind of new preparation method that obtains starting material, be fit to the felbinac of enterprise's production.
The present invention for the technical scheme that problem adopted of the above-mentioned proposition of solution is: the preparation method of felbinac includes the next coming in order step:
1) synthetic felbinac
With biphenyl is raw material, by chloromethylation, grignard reaction, hydrolysis three-step reaction synthetic the felbinac crude product; Wherein the mol ratio of biphenyl, formaldehyde, phosphoric acid, acetic acid is 1: 1: 3: 3, and concentrated hydrochloric acid is excessive, and feeds hydrogen chloride gas in chloromethylation in reaction soln, and the flow of described hydrogen chloride gas is 1~50L/h;
2) refining
Above-mentioned steps 1) gained felbinac crude product carries out recrystallization with 30~70% (weight) acetic acid solution, gets the pure product of felbinac.
Press such scheme, chloromethylation gained biphenyl methyl chloride carries out recrystallization with hexanaphthene in the described step 1).
Press such scheme, grignard reaction causes the Grignard reagent generation with monobromethane in the described step 1).
Press such scheme, the grignard reaction solvent for use is ether or tetrahydrofuran (THF) in the described step 1).
The present invention prepares the method for felbinac, and synthetic route is as follows:
Figure G2007100526680D00022
The feeding hydrogen chloride gas helps improving the productive rate of biphenyl methyl chloride; With hexanaphthene recrystallization biphenyl methyl chloride, can reduce the generation of by product in the grignard reaction; Cause grignard reaction with monobromethane, reduced temperature of reaction, shortened the reaction times, its infrared spectra and nuclear magnetic resonance spectrum are seen accompanying drawing 1~3.
Beneficial effect of the present invention is:
Use in the reaction process of the present invention, the bigger compound of toxigenicity not, environmental pollution is less; Raw material all is easy to obtain low price; Employed equipment also is the chemical industry common equipment, and is simple to operate, and the crude product total recovery is 38%~46%.
Description of drawings
Fig. 1 is the infrared spectrogram of products obtained therefrom felbinac of the present invention;
Fig. 2 is a products obtained therefrom of the present invention 1The H nmr spectrum;
Fig. 3 is a products obtained therefrom of the present invention 13The C nmr spectrum.
Embodiment
Further specify the present invention below by example, but the present invention not only that.
Embodiment 1:
(1) preparation biphenyl methyl chloride
On the 250ml there-necked flask, thermometer, mechanical stirrer, airway are housed by pipe connecting, reflux condensing tube, add biphenyl 15.4g (0.1mol) successively, formaldehyde 8.3g (0.1mol), phosphoric acid 34.5g (0.3mol), acetic acid 18.75g (0.3mol), concentrated hydrochloric acid 25ml.Be heated to 80~90 ℃ on the heating jacket that adjusts the temperature electronically, vigorous stirring 18~24 hours feeds HCl gas every 30 fens clockwise reaction solns, and the flow of hydrogen chloride gas is 45L/h.Stopped reaction is cooled to below 15 ℃, separates out solid.Filtration under diminished pressure, filter cake washing twice, about at every turn 40ml water is used the K of 20ml 5% again 2CO 3Solution washing once.Drain filter cake, change in the 250ml separating funnel, add the K of 40ml ether and 10ml 5% 2CO 3Solution, vibration is left standstill, and divides the lixiviating liquid layer, and ether layer adds Anhydrous potassium carbonate 20g placement and carried out drying in 24 hours.Boil off ether, with thick product hexanaphthene recrystallization 1 time that obtains.Product vacuum-drying.Get product 18.27g, purity is 83.62%, and this step yield is 75.4%.
(2) preparation felbinac
Condenser (top with calcium chloride tube) is housed, temperature is taken into account in the 250ml there-necked flask of normal pressure dropping funnel, adds magnesium chips 2.4g (0.1mol), the brilliant 0.2g (0.002mol) of iodine.Measure the 90ml ether, pour an amount of ether into and just cover magnesium chips, the biphenyl methyl chloride of residue ether dissolution previous step gained is stand-by in the normal pressure dropping funnel.Add the initiation reaction of 3ml monobromethane, slowly drip the diethyl ether solution of chloromethyl biphenyl after the brilliant color of iodine disappears, the dropping process is kept reaction with cooling bath a small amount of backflow.Dropwise, dropping funnel washes with the 10ml ether, and stirring at room is after 15 minutes, and 35 ℃ were refluxed 2 hours.Reaction finishes, and is cooled to below 8 ℃ with ice-water bath, feeds CO 2Gas 2~3 hours.Finish, in reaction solution, add an amount of ice cube, drip 10% dilute hydrochloric acid to acid.Ether is removed in distillation, filtration under diminished pressure, and washing leaching cake is drained.Filter cake is changed in the beaker, add 80ml 8%NaOH solution, be heated to 80 ℃ of dissolvings, cool to room temperature gets white casse solution, and filtration under diminished pressure is collected filtrate; Filter cake repeats twice by top operation again.Merge the filtrate of collecting, add 20% hcl acidifying, separate out white colloid.Filtration under diminished pressure, drying gets white flakey solid 8.80g, and fusing point is 158~161 ℃, and felbinac crude product total recovery is 41.9%.
(3) felbinac is refining
Above-mentioned felbinac crude product carries out recrystallization with 50% acetate, gets the pure product 5.52g of felbinac, content 99.74%, and 163~165 ℃ of fusing points, this step yield is 62.7%.
Embodiment 2:
(1) preparation biphenyl methyl chloride is with embodiment 1.
(2) condenser (top with calcium chloride tube) is housed, temperature is taken into account in the 250ml there-necked flask of normal pressure dropping funnel, adds magnesium chips 2.4g (0.1mol), the brilliant 0.2g (0.002mol) of iodine.Measure the 90ml tetrahydrofuran (THF), pour an amount of tetrahydrofuran (THF) into and just cover magnesium chips, the biphenyl methyl chloride of residue tetrahydrofuran (THF) dissolving previous step gained is stand-by in the normal pressure dropping funnel.Other the same step.Get felbinac crude product 9.7 grams, the crude product total recovery is 45.6%.
(3) felbinac is refining carries out recrystallization with embodiment 1 with 70% acetate, gets the pure product 5.78g of felbinac, content 99.79%, and 163~165 ℃ of fusing points, this step yield is 59.5%.

Claims (4)

1. the preparation method of felbinac is characterized in that including the next coming in order step:
1) synthetic felbinac
With biphenyl is raw material, by chloromethylation, grignard reaction, hydrolysis three-step reaction synthetic the felbinac crude product; Wherein the mol ratio of the biphenyl in the chloromethylation, formaldehyde, phosphoric acid, acetic acid is 1: 1: 3: 3, and concentrated hydrochloric acid is excessive, and feeds hydrogen chloride gas in chloromethylation in reaction soln, and the flow of described hydrogen chloride gas is 1~50L/h;
2) refining
Above-mentioned steps 1) gained felbinac crude product carries out recrystallization with 30~70% (weight) acetic acid solution, gets the pure product of felbinac.
2. by the preparation method of the described felbinac of claim 1, it is characterized in that chloromethylation gained biphenyl methyl chloride carries out recrystallization with hexanaphthene in the described step 1).
3. by the preparation method of claim 1 or 2 described felbinac, it is characterized in that grignard reaction causes the Grignard reagent generation with monobromethane in the described step 1).
4. by the preparation method of claim 1 or 2 described felbinac, it is characterized in that the grignard reaction solvent for use is ether or tetrahydrofuran (THF) in the described step 1).
CN200710052668A 2007-07-09 2007-07-09 Method for preparing felbinac Expired - Fee Related CN101143815B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200710052668A CN101143815B (en) 2007-07-09 2007-07-09 Method for preparing felbinac

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200710052668A CN101143815B (en) 2007-07-09 2007-07-09 Method for preparing felbinac

Publications (2)

Publication Number Publication Date
CN101143815A CN101143815A (en) 2008-03-19
CN101143815B true CN101143815B (en) 2010-05-19

Family

ID=39206570

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200710052668A Expired - Fee Related CN101143815B (en) 2007-07-09 2007-07-09 Method for preparing felbinac

Country Status (1)

Country Link
CN (1) CN101143815B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102503805B (en) * 2011-10-26 2013-11-13 上海图帕医药科技有限公司 Method for preparing 4-felbinac through rearrangement reaction
CN103086875A (en) * 2013-02-01 2013-05-08 山东省医药工业研究所 Synthetic method of felbinac non-steroidal anti-inflammatory agent
CN106431911B (en) * 2016-09-28 2021-05-28 黄石市利福达医药化工有限公司 Preparation and purification method of 4-felbinac
CN110028403B (en) * 2019-04-19 2020-08-11 四川大学 Method for synthesizing succinic acid compound
CN111574354A (en) * 2020-06-18 2020-08-25 安徽鼎旺医药有限公司 Biphenylacetic acid and preparation method thereof
CN116063153A (en) * 2021-10-29 2023-05-05 中国科学院大连化学物理研究所 Synthesis method of 4-diphenyl methanol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张田林等.4-联苯乙酸的新法合成.中国医药工业杂质34 7.2003,34(7),318-319.
张田林等.4-联苯乙酸的新法合成.中国医药工业杂质34 7.2003,34(7),318-319. *

Also Published As

Publication number Publication date
CN101143815A (en) 2008-03-19

Similar Documents

Publication Publication Date Title
CN101143815B (en) Method for preparing felbinac
CN101654445B (en) Compound for preparing ramelteon, preparation method thereof and application thereof
CN103524383B (en) Method for preparing peramivir
CN102101830A (en) Method for preparing trinexapac-ethyl
CN101671352A (en) Method for preparing fluoride-bearing phenyloboric acid
CN112010770A (en) Novel production method of glycine ethyl ester hydrochloride
CN103396318B (en) Synthetic process for 2,4-dinitroanisole
CN101239934A (en) Technique for producing rivastigmine hydrogen tartrate
CN107954882A (en) A kind of preparation method of 2- amino -2- (the 4- tert-butyl group -2- ethoxyl phenenyls) ethanol
CN101735118B (en) Process method for synthesizing tertiary butyl sulfinyl amine by using silicohydride as protective reagent
CN100497318C (en) Method for preparing 2,4,6-trichloro pyrimidine
CN108530301A (en) A kind of synthetic method of tri- fluorin benzyl amines of 2,4,6-
CN101544563A (en) The present invention relates to a preparing method of 2-methyl cyclohexyl acetate.
CN102250005B (en) Preparation method of Eslicarbazepine
CN103665038B (en) A kind of carbon phosphorus chirality dialkyl phosphine oxide and synthetic method thereof
CN104926847B (en) A kind of synthesis boron aminated compounds technique and products application
CN102363598B (en) Method for preparing high-purity gabapentin
CN101698633A (en) Method for preparing trifluoromethyl benzyl alcohol by Grignard reaction
CN106316921A (en) Preparation method for acemetacin
CN101265201B (en) Method for synthesizing tramadol hydrochloride
IL168110A (en) Process for production of an acetylenic compound
CN109879775A (en) A kind of environment-friendly preparation method of 5-ALA hydrochloride intermediate
CN103408439A (en) Chemical synthetic method of norbelladine
CN103086877A (en) Splitting method of 2-hydracrylic acid racemic mixture
CN108503571B (en) Synthetic method of vildagliptin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Yongan Pharmaceutical Co., Ltd., Qianjiang

Assignor: Wuhan Institute of Technology

Contract record no.: 2011420000184

Denomination of invention: Preparation of non-steroidal anti-inflammatory medicine biphenylacetic acid

Granted publication date: 20100519

License type: Exclusive License

Open date: 20080319

Record date: 20110714

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100519

Termination date: 20140709

EXPY Termination of patent right or utility model